Stanford University
Stanford University
Palo Alto, California, United States11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis | eye disorder, retinal degeneration, retinal disorder, retinoschisis | Recruiting | Phase 3 | 2026-09-29 | NCT05878860 | |
| Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial | eye disorder, myopia, refractive error | Recruiting | Phase 3 | 2026-09-21 | NCT07567040 | |
| RB-PDT for Fusarium Keratitis: The LUMIERE Study | Fusarium Keratitis | Not yet recruiting | Phase 3 | 2026-08-17 | NCT07743489 | |
| Descemet Endothelial Thickness Comparison Trial I | Fuchs | Active, not recruiting | Phase 3 | 2026-08-17 | NCT05289661 | |
| Descemet Endothelial Thickness Comparison Trial II | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Fuchs' endothelial dystrophy, corneal disorder, corneal dystrophy, eye disorder, hereditary disease | Recruiting | Phase 3 | 2026-08-17 | NCT05275972 | |
| A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control | eye disorder, myopia, refractive error | Recruiting | Phase 3 | 2026-06-26 | NCT07095894 | |
| Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Subcutaneous Emphysema, alpha 1-antitrypsin deficiency, hereditary disease, liver disorder, lung disorder, pulmonary emphysema, respiratory system disorder | Recruiting | Phase 3 | 2026-05-13 | NCT05677971 | |
| Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, amblyopia, brain disorder, central nervous system disorder, eye disorder, nervous system disorder, vision disorder | Recruiting | Phase 3 | 2026-02-11 | NCT06524882 | |
| Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, amblyopia, brain disorder, central nervous system disorder, eye disorder, nervous system disorder, vision disorder | Recruiting | Phase 3 | 2026-02-11 | NCT06380517 | |
| A Randomized Trial to Evaluate Sequential vs Simultaneous Patching | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, amblyopia, brain disorder, central nervous system disorder, eye disorder, nervous system disorder, vision disorder | Recruiting | Phase 3 | 2026-02-11 | NCT04378790 | |
| Clinical and Genetic Analysis of ROP | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Infant, Newborn, Diseases, Infant, Premature, Diseases, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, eye disorder, pregnancy disorder, retinal disorder, retinopathy of prematurity | Recruiting | Not stated | 2022-04-20 | NCT04420156 |